 CAMBRIDGE, Mass., Sept. 30, 2021 GLOBE NEWSWIRE -- Editas Medicine, Inc. Nasdaq: EDIT, a leading genome editing company, will present at Chardans 5th Annual Genetic Medicines Conference on Monday, October 4, 2021 at 8:30 a.m. ET. 